TriSalus Life Sciences (TLSI) Change in Intangibles (2022 - 2023)
TriSalus Life Sciences posted quarterly Change in Intangibles of $328000.0 for Q4 2023, up 382.35% year-on-year from $68000.0 in Q4 2022, and up 135.97% on a QoQ basis from $139000.0 in Q3 2023.
TriSalus Life Sciences (TLSI) has 2 years of Change in Intangibles data on file, last reported at $328000.0 in Q4 2023.
- For the quarter ending Q4 2023, Change in Intangibles rose 382.35% year-over-year to $328000.0; the trailing twelve-month figure through Jun 2024 stood at $467000.0 (changed N/A YoY), and the FY2023 full-year result was $533000.0, up 306.87% from the prior year.
- Change in Intangibles for Q4 2023 stood at $328000.0, up from $139000.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $328000.0 in Q4 2023 and bottomed at -$1000.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 328,000.00 |
| Dec 31, 2023 | 328,000.00 |
| Sep 30, 2023 | 139,000.00 |
| Sep 30, 2023 | 139,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 68,000.00 |
| Dec 31, 2022 | 68,000.00 |